Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 10, 2018 - Issue
Submit an article Journal homepage
131
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England

Jie Meng1 Analytica Laser, London, UK
,
Johanna Lister1 Analytica Laser, London, UKCorrespondence[email protected]
,
Anne-Lise Vataire2 Ipsen Pharma, Boulogne-Billancourt, France
,
Roman Casciano1 Analytica Laser, London, UK
&
Jerome Dinet2 Ipsen Pharma, Boulogne-Billancourt, France
Pages 243-250 | Published online: 23 Apr 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.